A Study Evaluating the Bioavailability of Oral Insulin (N11005)

NCT04975022 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER_GOV

Sponsor class

Conditions

PK, PD, and Safety

Interventions

DRUG: N11005
DRUG: Novolin R

Sponsor

Beijing Hospital